CBNGO00049—Key glycosyl donor for glycoprotein synthesis and modification

S2G2-PEG1 oxazoline is a class of glycosyl oxazoline derivatives with clear structure and specific reactivity, which plays an important role in modern glycochemistry and glycobiology research. As an efficient glycosylation donor, it provides core chemical tools for the precise synthesis and engineering of complex glycoproteins, especially in the fields of therapeutic antibodies, vaccine development, and protein function research.

Chemical information

Chemical name: S2G2-PEG1 oxazoline (CBNGO00049)

Chemical formula: C₈₄H₁₃₉N₁₃O₅₆

Molecular weight: 2227.07 g/mol

Category: Glycan Oxazoline

Structural features

The design of S2G2-PEG1 oxazoline combines sugar chain structure and linker engineering. Its core features are:

Oxazoline ring active center: The oxazoline ring at the end of the molecule is its key functional group. This cyclic structure, catalyzed by highly site-selective enzymes (such as endoglycosidases Endo-S, Endo-F, etc.), can efficiently and specifically undergo a transglycosylation reaction with specific sugar chain receptors on proteins or antibodies (usually natural or engineered N-linked glycosylation sites) to achieve the transfer or replacement of sugar chains.

Precise sugar chain structure (S2G2): This part represents a complex N-glycan core with a specific branched structure. This clear glycoform determines the subsequent biological properties of the glycoprotein, such as the specificity of binding to the receptor, half-life in the body, and immunogenicity regulation.

Flexible PEG connecting bridge: The introduced polyethylene glycol (PEG) unit serves as a connecting arm, which enhances the water solubility and flexibility of the entire molecule, helps reduce steric hindrance, and makes the oxazoline active center more accessible to the enzyme catalytic pocket, thus improving the efficiency and compatibility of the transglycosylation reaction.

Main applications and advantages

Glycosylation remodeling of therapeutic proteins

In the field of biopharmaceuticals, the glycosylation pattern of proteins (especially monoclonal antibodies) directly affects their efficacy, stability and immune properties. S2G2-PEG1 oxazoline can be used as a homogenized, designed sugar chain donor to replace the heterogeneous Fc sugar chains on natural antibodies with uniform, functionally optimized glycoforms (such as defucosylated sugar chains to enhance the ADCC effect, or sialylated sugar chains to modulate anti-inflammatory activity) through enzymatic transglycosylation reactions, thereby accurately optimizing the function of therapeutic antibodies.

Development of glycoprotein vaccines and conjugates

Based on the imitation of pathogen surface carbohydrate antigens or tumor-associated carbohydrate antigens, the design of specific sugar chain oxazolines can be used to construct structurally uniform glycoprotein vaccines. Efficiently coupling it to a carrier protein can induce the production of high-titer, high-specific protective antibodies. This strategy has broad prospects in the development of antiviral, antibacterial and anticancer vaccines.

Basic glycobiology research tools

S2G2-PEG1 oxazoline provides a standardized probe for studying at the molecular level how glycosylation affects protein folding, stability, intracellular trafficking, and signaling. By preparing model proteins with specific glycoform modifications, researchers can clearly analyze the structure-activity relationship between sugar chain structure and biological function.

Enzyme mechanism research and enzyme engineering

This type of compound is an ideal substrate for studying the catalytic mechanism, substrate specificity and reaction kinetics of endoglycosidases and their mutants. Its clear structure helps reveal the details of the interaction between enzymes and substrates, thereby guiding the rational design of enzyme molecules to expand the range of its catalytic glycoforms or change its receptor preference.

Conclusion

S2G2-PEG1 oxazoline represents a key reagent in the technology of chemoenzymatic synthesis of glycoproteins. It integrates a clear sugar chain structure, efficient enzymatic reaction activity and good physical and chemical properties, providing a powerful chemical tool for the precise design and functional improvement of glycoprotein drugs, as well as for in-depth exploration of the molecular basis of sugar life. As glycoscience becomes increasingly important in biomedicine, the role of such well-designed glycosyl oxazolines will become increasingly important.

The above information is provided by the editor of KASONS and is for scientific research only.